Source link : https://www.newshealth.biz/health-news/do-statins-improve-nasopharyngeal-cancer-outcomes/
TOPLINE: Statin use during concurrent chemoradiotherapy (CCRT) for advanced nasopharyngeal cancer (NPC) is associated with a 52% reduction in all-cause mortality. Higher cumulative defined daily doses of statins correlate with improved survival outcomes, particularly with rosuvastatin and atorvastatin. METHODOLOGY: Statins have demonstrated potential anticancer effects in various malignancies, including the ability to enhance chemotherapy efficacy […]
Author : News Health
Publish date : 2024-11-18 11:18:25
Copyright for syndicated content belongs to the linked Source.